Amedisys Reports Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Amedisys (AMED) Tops Q2 EPS by 10c
July 29, 2015 7:41 AM EDTAmedisys (NASDAQ: AMED) reported Q2 EPS of $0.43, $0.10 better than the analyst estimate of $0.33. Revenue for the quarter came in at $314.2 million versus the consensus estimate of $307.11 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
... More
